Question 1 · Easy
Postmenopausal bleeding in a woman taking tamoxifen for breast cancer is most worrying for which condition?
- AEndometrial carcinoma
- BAtrophic vaginitis
- CCervical ectropion
- DOvarian granulosa cell tumour
Show answerHide answer
Answer: A · Endometrial carcinoma
Tamoxifen is an oestrogen antagonist in breast tissue but a partial agonist in the endometrium, raising the risk of endometrial hyperplasia, polyps and carcinoma about two- to threefold. Any postmenopausal bleeding on tamoxifen needs transvaginal ultrasound and endometrial biopsy. Raloxifene does not stimulate the endometrium.
- B: Atrophic vaginitis is common, but on tamoxifen cancer must be excluded first.
- C: Ectropion is a benign cervical finding, not linked to tamoxifen.
- D: Granulosa cell tumours are rare and unrelated to tamoxifen.
Remember this
Tamoxifen is an endometrial agonist: bleeding on it needs evaluation for endometrial cancer.